Eleonore Ofosu-Antwi

Eleonore Ofosu-Antwi

Associate

P: 973.757.1022

F: 973.757.1090

 eofosuantwi@walsh.law
LinkedIn
vCard

Print Bio
Practice Areas:
  • Business & Commercial Litigation
  • Class Action Defense
  • Intellectual Property & Trade Secret Litigation

 

States Admitted to Practice:
  • New Jersey
  • New York

 

Courts Admitted to Practice:
  • US Court of Appeals for the Third Circuit
  • US District Court for the District of New Jersey

 

Education:
  • Seton Hall University School of Law (2009)
  • Colgate University (2006)

 

Affiliations:
  • New Jersey State Bar Association
  • The Association of the Federal Bar of New Jersey
  • Essex County Bar Association

Eleonore Ofosu-Antwi’s practice focuses primarily on federal and complex commercial litigation, including business disputes, antitrust, intellectual property and class action defense. In her role as New Jersey litigation counsel, Eleonore has extensive experience in patent litigation concerning a range of technologies, including pharmaceuticals, biotechnology, and chemical industries. She has knowledge and experience in antitrust litigation spanning a wide range of topics, including reverse payment settlements of patent disputes, sham litigaton, fraudulent procurement of patents and other antitrust theories, and has also successfully handled complex cases involving products liability, mass torts, commercial contracts, and trademark infringement.

 

Prior to joining the firm, Eleonore served as a judicial law clerk to the Honorable Susan D. Wigenton, U.S.D.J., in the United States District Court for the District of New Jersey, and the Honorable Edwin H. Stern, Presiding Judge for Administration, in the Superior Court of New Jersey, Appellate Division. She earned her J.D. from the Seton Hall University School of Law, where was a member of the Law Review. She was also awarded the Clyde Ferguson Scholarship, served as a Teaching Fellow for Seton Hall’s Academic Success Program, and participated in the Center for Social Justice’s Immigrants’ Rights/International Human Rights Clinic. During law school, she served as a judicial extern to the Honorable Peter G. Sheridan, U.S.D.J., in the United States District Court for the District of New Jersey.

Representative Experience
  • Representation of various brand and generic pharmaceutical companies as local counsel in Hatch-Waxman and biosimilar ligitation involving various drug products.
  • Representation of Wyeth Inc. entities in defending putative class actions from direct and indirect purchasers of the pharmaceutical product Effexor XR®, which assert antitrust violations arising from Wyeth’s patents regarding Effexor XR® and related patent litigation with pharmaceutical companies seeking to sell generic versions of the product.
  • Represention of Pfizer Inc. entities in defending putative class actions from direct and indirect purchasers of the pharmaceutical product Lipitor®, which assert antitrust violations arising from Pfizer’s patents regarding Lipitor® and related patent litigation with pharmaceutical companies seeking to sell generic versions of the product.
  • Representation of large pharmaceutical companies in “reverse payment” settlements of patent disputes.
  • Counsel for suppliers in asbestos and other toxic tort suits filed in New York State Court.
Decisions
  • AstraZeneca LP v. Breath Ltd., 2015 U.S. App. LEXIS 7525 (Fed. Cir., May 7, 2015)
  • AstraZeneca LP v. Breath Limited, 88 F. Supp. 3d 326 (D.N.J. 2015)
  • Cipher Pharms. Inc. v. Actavis Labs. FL, Inc., 2015 U.S. Dist. LEXIS 51224 (D.N.J. Apr. 20, 2015)
  • In re Effexor XR Antitrust Litig., 2014 U.S. Dist. LEXIS 142206 (D.N.J. Oct. 6, 2014)
  • Depomed, Inc. v. Actavis Elizabeth LLC, LEXIS 118096 (D.N.J. August 18, 2014)
  • Depomed Inc. v. Purdue Pharma L.P., 2014 U.S. Dist. LEXIS 102109 (D.N.J. July 25, 2014)
  • In re Lipitor Antitrust Litig., 46 F. Supp. 3d 523 (D.N.J. 2014)
  • Gilead Scis., Inc. v. Natco Pharma Ltd., 2012 U.S. Dist. LEXIS 180717 (D.N.J. Dec. 21, 2012)
  • Demodulation, Inc. v. Applied DNA Scis., Inc., 2011 U.S. Dist. LEXIS 147126 (D.N.J. Dec. 22, 2011)